HGV infection in patients affected with HCV chronic liver disease: prevalence and eligibility to the interferon treatment

HGV infection in patients affected with HCV chronic liver disease: prevalence and eligibility to the interferon treatment / G.P. Benetti, G. Ramella, M. Lazza, A. Corbellini, M.L. Ribero, A. Tagger. - In: HEPATOLOGY. - ISSN 0270-9139. - 24:4 , Pt 2(1996), pp. 483-483. ((Intervento presentato al 47. convegno The American Association for the Study of Liver Diseases AASLD tenutosi a Chicago Illinois nel 1996.